Search research articles
Contact Us
Filters
Showing results (51-60 of 71) with videos related to
Page
of 8
Sort By:
Anesthesiology
|
April 17, 2004
Clinical pharmacology of GW280430A in humans
Matthew R Belmont, Cynthia A Lien, Joseph Tjan, et al.
Anesthesiology
|
May 1, 1995
The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia
M R Belmont, C A Lien, S Quessy, et al.
British Journal of Anaesthesia
|
August 1, 1986
Clinical pharmacology of atracurium given in high dose
R P Scott, J J Savarese, S J Basta, et al.
Anesthesiology
|
May 1, 1995
The cardiovascular effects and histamine-releasing properties of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia
C A Lien, M R Belmont, A Abalos, et al.
Anesthesiology
|
February 1, 1989
Neuromuscular and cardiovascular effects of mivacurium in children
N G Goudsouzian, J K Alifimoff, C Eberly, et al.
Anesthesia and Analgesia
|
September 1, 1982
Clinical pharmacology of atracurium besylate (BW 33A): a new non-depolarizing muscle relaxant
S J Basta, H H Ali, J J Savarese, et al.
British Journal of Anaesthesia
|
June 1, 1985
Atracurium: clinical strategies for preventing histamine release and attenuating the haemodynamic response
R P Scott, J J Savarese, S J Basta, et al.
Anesthesiology
|
October 1, 1988
Clinical pharmacology of doxacurium chloride. A new long-acting nondepolarizing muscle relaxant
S J Basta, J J Savarese, H H Ali, et al.
Anesthesiology
|
June 8, 2010
Rapid chemical antagonism of neuromuscular blockade by L-cysteine adduction to and inactivation of the olefinic (double-bonded) isoquinolinium diester compounds gantacurium (AV430A), CW 002, and CW 011
John J Savarese, Jeff D McGilvra, Hiroshi Sunaga, et al.
British Journal of Anaesthesia
|
November 1, 1988
Clinical pharmacology of mivacurium chloride (BW B1090U) infusion: comparison with vecuronium and atracurium
H H Ali, J J Savarese, P B Embree, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 71) with videos related to
Sort By:
Page
of 8
Anesthesiology
|
April 17, 2004
Clinical pharmacology of GW280430A in humans
Matthew R Belmont, Cynthia A Lien, Joseph Tjan, et al.
Anesthesiology
|
May 1, 1995
The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia
M R Belmont, C A Lien, S Quessy, et al.
British Journal of Anaesthesia
|
August 1, 1986
Clinical pharmacology of atracurium given in high dose
R P Scott, J J Savarese, S J Basta, et al.
Anesthesiology
|
May 1, 1995
The cardiovascular effects and histamine-releasing properties of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia
C A Lien, M R Belmont, A Abalos, et al.
Anesthesiology
|
February 1, 1989
Neuromuscular and cardiovascular effects of mivacurium in children
N G Goudsouzian, J K Alifimoff, C Eberly, et al.
Anesthesia and Analgesia
|
September 1, 1982
Clinical pharmacology of atracurium besylate (BW 33A): a new non-depolarizing muscle relaxant
S J Basta, H H Ali, J J Savarese, et al.
British Journal of Anaesthesia
|
June 1, 1985
Atracurium: clinical strategies for preventing histamine release and attenuating the haemodynamic response
R P Scott, J J Savarese, S J Basta, et al.
Anesthesiology
|
October 1, 1988
Clinical pharmacology of doxacurium chloride. A new long-acting nondepolarizing muscle relaxant
S J Basta, J J Savarese, H H Ali, et al.
Anesthesiology
|
June 8, 2010
Rapid chemical antagonism of neuromuscular blockade by L-cysteine adduction to and inactivation of the olefinic (double-bonded) isoquinolinium diester compounds gantacurium (AV430A), CW 002, and CW 011
John J Savarese, Jeff D McGilvra, Hiroshi Sunaga, et al.
British Journal of Anaesthesia
|
November 1, 1988
Clinical pharmacology of mivacurium chloride (BW B1090U) infusion: comparison with vecuronium and atracurium
H H Ali, J J Savarese, P B Embree, et al.
Page
of 8